Retrospective analysis of prognosis for scirrhous-type gastric cancer: One institution's experience

Rieko Nakamura, Yoshiro Saikawa, Norihito Wada, Masashi Yoshida, Tetsuro Kubota, Koichiro Kumai, Masaki Kitajima

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Background. Scirrhous gastric cancer is biologically aggressive, and the prognosis is poor even with curative surgery. We compared outcomes with different therapies in order to identify prognostic factors. Methods. Records for 83 patients, who were treated between 1991 and 2004, were evaluated for survival and stage, treatment, and clinicopathological factors. Results. Cumulative 5-year overall survival was 10.2% for all 83 patients, including 27 (32.5%) patients with stage II/III disease and 56 (67.4%) with stage IV disease. The 5-year overall survival rate and median survival time for patients with stage II/III disease after curative surgery were 24.3% and 1150 days. For patients with stage IV disease, 2-year and 5-year survival rates after initial surgery were 13.7% and 0% and median survival was 250 days. In contrast, preoperative chemotherapy for advanced, unresectable disease produced 2-year and 3-year overall survival rates of 53.6% and 26.8% and medican survival was 910 days. Conclusion. Aggressive surgery alone does not seem to improve outcome, but preoperative chemotherapy might be beneficial and should be investigated further.

Original languageEnglish
Pages (from-to)291-294
Number of pages4
JournalInternational Journal of Clinical Oncology
Volume12
Issue number4
DOIs
Publication statusPublished - 2007 Aug

Fingerprint

Stomach Neoplasms
Survival
Survival Rate
Drug Therapy
Therapeutics

Keywords

  • Chemotherapy
  • Prognosis
  • Scirrhous-type gastric cancer
  • Surgery

ASJC Scopus subject areas

  • Oncology

Cite this

Retrospective analysis of prognosis for scirrhous-type gastric cancer : One institution's experience. / Nakamura, Rieko; Saikawa, Yoshiro; Wada, Norihito; Yoshida, Masashi; Kubota, Tetsuro; Kumai, Koichiro; Kitajima, Masaki.

In: International Journal of Clinical Oncology, Vol. 12, No. 4, 08.2007, p. 291-294.

Research output: Contribution to journalArticle

Nakamura, Rieko ; Saikawa, Yoshiro ; Wada, Norihito ; Yoshida, Masashi ; Kubota, Tetsuro ; Kumai, Koichiro ; Kitajima, Masaki. / Retrospective analysis of prognosis for scirrhous-type gastric cancer : One institution's experience. In: International Journal of Clinical Oncology. 2007 ; Vol. 12, No. 4. pp. 291-294.
@article{067775b28b5c4575a8c48bdb7184549e,
title = "Retrospective analysis of prognosis for scirrhous-type gastric cancer: One institution's experience",
abstract = "Background. Scirrhous gastric cancer is biologically aggressive, and the prognosis is poor even with curative surgery. We compared outcomes with different therapies in order to identify prognostic factors. Methods. Records for 83 patients, who were treated between 1991 and 2004, were evaluated for survival and stage, treatment, and clinicopathological factors. Results. Cumulative 5-year overall survival was 10.2{\%} for all 83 patients, including 27 (32.5{\%}) patients with stage II/III disease and 56 (67.4{\%}) with stage IV disease. The 5-year overall survival rate and median survival time for patients with stage II/III disease after curative surgery were 24.3{\%} and 1150 days. For patients with stage IV disease, 2-year and 5-year survival rates after initial surgery were 13.7{\%} and 0{\%} and median survival was 250 days. In contrast, preoperative chemotherapy for advanced, unresectable disease produced 2-year and 3-year overall survival rates of 53.6{\%} and 26.8{\%} and medican survival was 910 days. Conclusion. Aggressive surgery alone does not seem to improve outcome, but preoperative chemotherapy might be beneficial and should be investigated further.",
keywords = "Chemotherapy, Prognosis, Scirrhous-type gastric cancer, Surgery",
author = "Rieko Nakamura and Yoshiro Saikawa and Norihito Wada and Masashi Yoshida and Tetsuro Kubota and Koichiro Kumai and Masaki Kitajima",
year = "2007",
month = "8",
doi = "10.1007/s10147-007-0683-9",
language = "English",
volume = "12",
pages = "291--294",
journal = "International Journal of Clinical Oncology",
issn = "1341-9625",
publisher = "Springer Japan",
number = "4",

}

TY - JOUR

T1 - Retrospective analysis of prognosis for scirrhous-type gastric cancer

T2 - One institution's experience

AU - Nakamura, Rieko

AU - Saikawa, Yoshiro

AU - Wada, Norihito

AU - Yoshida, Masashi

AU - Kubota, Tetsuro

AU - Kumai, Koichiro

AU - Kitajima, Masaki

PY - 2007/8

Y1 - 2007/8

N2 - Background. Scirrhous gastric cancer is biologically aggressive, and the prognosis is poor even with curative surgery. We compared outcomes with different therapies in order to identify prognostic factors. Methods. Records for 83 patients, who were treated between 1991 and 2004, were evaluated for survival and stage, treatment, and clinicopathological factors. Results. Cumulative 5-year overall survival was 10.2% for all 83 patients, including 27 (32.5%) patients with stage II/III disease and 56 (67.4%) with stage IV disease. The 5-year overall survival rate and median survival time for patients with stage II/III disease after curative surgery were 24.3% and 1150 days. For patients with stage IV disease, 2-year and 5-year survival rates after initial surgery were 13.7% and 0% and median survival was 250 days. In contrast, preoperative chemotherapy for advanced, unresectable disease produced 2-year and 3-year overall survival rates of 53.6% and 26.8% and medican survival was 910 days. Conclusion. Aggressive surgery alone does not seem to improve outcome, but preoperative chemotherapy might be beneficial and should be investigated further.

AB - Background. Scirrhous gastric cancer is biologically aggressive, and the prognosis is poor even with curative surgery. We compared outcomes with different therapies in order to identify prognostic factors. Methods. Records for 83 patients, who were treated between 1991 and 2004, were evaluated for survival and stage, treatment, and clinicopathological factors. Results. Cumulative 5-year overall survival was 10.2% for all 83 patients, including 27 (32.5%) patients with stage II/III disease and 56 (67.4%) with stage IV disease. The 5-year overall survival rate and median survival time for patients with stage II/III disease after curative surgery were 24.3% and 1150 days. For patients with stage IV disease, 2-year and 5-year survival rates after initial surgery were 13.7% and 0% and median survival was 250 days. In contrast, preoperative chemotherapy for advanced, unresectable disease produced 2-year and 3-year overall survival rates of 53.6% and 26.8% and medican survival was 910 days. Conclusion. Aggressive surgery alone does not seem to improve outcome, but preoperative chemotherapy might be beneficial and should be investigated further.

KW - Chemotherapy

KW - Prognosis

KW - Scirrhous-type gastric cancer

KW - Surgery

UR - http://www.scopus.com/inward/record.url?scp=34547883897&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547883897&partnerID=8YFLogxK

U2 - 10.1007/s10147-007-0683-9

DO - 10.1007/s10147-007-0683-9

M3 - Article

C2 - 17701009

AN - SCOPUS:34547883897

VL - 12

SP - 291

EP - 294

JO - International Journal of Clinical Oncology

JF - International Journal of Clinical Oncology

SN - 1341-9625

IS - 4

ER -